• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脆性位点的 DNA 断裂会在人类甲状腺细胞中产生致癌性的 RET/PTC 重排。

DNA breaks at fragile sites generate oncogenic RET/PTC rearrangements in human thyroid cells.

机构信息

Department of Pathology and Laboratory Medicine, University of Pittsburgh, Pittsburgh, PA, USA.

出版信息

Oncogene. 2010 Apr 15;29(15):2272-80. doi: 10.1038/onc.2009.502. Epub 2010 Jan 25.

DOI:10.1038/onc.2009.502
PMID:20101222
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2855398/
Abstract

Human chromosomal fragile sites are regions of the genome that are prone to DNA breakage, and are classified as common or rare, depending on their frequency in the population. Common fragile sites frequently coincide with the location of genes involved in carcinogenic chromosomal translocations, suggesting their role in cancer formation. However, there has been no direct evidence linking breakage at fragile sites to the formation of a cancer-specific translocation. Here, we studied the involvement of fragile sites in the formation of RET/PTC rearrangements, which are frequently found in papillary thyroid carcinoma (PTC). These rearrangements are commonly associated with radiation exposure; however, most of the tumors found in adults are not linked to radiation. In this study, we provide structural and biochemical evidence that the RET, CCDC6 and NCOA4 genes participating in two major types of RET/PTC rearrangements, are located in common fragile sites FRA10C and FRA10G, and undergo DNA breakage after exposure to fragile site-inducing chemicals. Moreover, exposure of human thyroid cells to these chemicals results in the formation of cancer-specific RET/PTC rearrangements. These results provide the direct evidence for the involvement of chromosomal fragile sites in the generation of cancer-specific rearrangements in human cells.

摘要

人类染色体脆性位点是基因组中容易发生 DNA 断裂的区域,根据其在人群中的频率,可分为常见和罕见脆性位点。常见脆性位点经常与致癌染色体易位涉及的基因位置重合,这表明它们在癌症形成中起作用。然而,目前还没有直接证据表明脆性位点的断裂与特定癌症易位的形成有关。在这里,我们研究了脆性位点在 RET/PTC 重排形成中的作用,RET/PTC 重排常见于甲状腺乳头状癌(PTC)。这些重排通常与辐射暴露有关;然而,大多数在成人中发现的肿瘤与辐射无关。在这项研究中,我们提供了结构和生化证据,表明参与两种主要类型的 RET/PTC 重排的 RET、CCDC6 和 NCOA4 基因位于常见脆性位点 FRA10C 和 FRA10G 中,并在暴露于脆性位点诱导化学物质后发生 DNA 断裂。此外,这些化学物质暴露于人类甲状腺细胞会导致特定的 RET/PTC 重排。这些结果为染色体脆性位点参与人类细胞中特定癌症重排的产生提供了直接证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226a/2855398/4563915fe164/nihms-166296-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226a/2855398/714ed06a434c/nihms-166296-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226a/2855398/e57075014931/nihms-166296-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226a/2855398/44ed56eb01e3/nihms-166296-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226a/2855398/4563915fe164/nihms-166296-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226a/2855398/714ed06a434c/nihms-166296-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226a/2855398/e57075014931/nihms-166296-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226a/2855398/44ed56eb01e3/nihms-166296-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226a/2855398/4563915fe164/nihms-166296-f0004.jpg

相似文献

1
DNA breaks at fragile sites generate oncogenic RET/PTC rearrangements in human thyroid cells.脆性位点的 DNA 断裂会在人类甲状腺细胞中产生致癌性的 RET/PTC 重排。
Oncogene. 2010 Apr 15;29(15):2272-80. doi: 10.1038/onc.2009.502. Epub 2010 Jan 25.
2
DNA fragile site breakage as a measure of chemical exposure and predictor of individual susceptibility to form oncogenic rearrangements.DNA脆性位点断裂作为化学暴露的一种衡量指标以及个体形成致癌重排易感性的预测指标。
Carcinogenesis. 2017 Mar 1;38(3):293-301. doi: 10.1093/carcin/bgw210.
3
DNA topoisomerases participate in fragility of the oncogene RET.DNA拓扑异构酶参与原癌基因RET的脆性。
PLoS One. 2013 Sep 11;8(9):e75741. doi: 10.1371/journal.pone.0075741. eCollection 2013.
4
A post-irradiation-induced replication stress promotes RET proto-oncogene breakage.辐照诱导的复制应激促进 RET 原癌基因断裂。
Eur Thyroid J. 2024 Aug 23;13(4). doi: 10.1530/ETJ-24-0028. Print 2024 Aug 1.
5
Molecular analysis of the RET and NTRK1 gene rearrangements in papillary thyroid carcinoma in the Polish population.波兰人群中甲状腺乳头状癌RET和NTRK1基因重排的分子分析
Mutat Res. 2006 Jul 25;599(1-2):26-35. doi: 10.1016/j.mrfmmm.2005.12.013. Epub 2006 Feb 17.
6
Transcript level modulates the inherent oncogenicity of RET/PTC oncoproteins.转录水平调节RET/PTC癌蛋白的内在致癌性。
Cancer Res. 2009 Jun 1;69(11):4861-9. doi: 10.1158/0008-5472.CAN-08-4425.
7
[RET/PTC Gene Rearrangements in the Sporadic and Radiogenic Thyroid Tumors: Molecular Genetics, Radiobiology and Molecular Epidemiology].[散发性和放射性甲状腺肿瘤中的RET/PTC基因重排:分子遗传学、放射生物学和分子流行病学]
Radiats Biol Radioecol. 2015 May-Jun;55(3):229-49.
8
[Dose-Response Dependences for Frequency of RET/PTC Gene Rearrangements in Papillary Thyroid Carcinoma after Irradiation. Simple Pooling Analysis of Molecular Epidemiological Data].[甲状腺乳头状癌放疗后RET/PTC基因重排频率的剂量反应依赖性。分子流行病学数据的简单合并分析]
Radiats Biol Radioecol. 2016 Jan-Feb;56(1):5-25.
9
Suitability of animal models for studying radiation-induced thyroid cancer in humans: evidence from nuclear architecture.从核架构看用于研究人类辐射诱导甲状腺癌的动物模型的适宜性:证据。
Thyroid. 2011 Dec;21(12):1331-7. doi: 10.1089/thy.2011.0269.
10
RET rearrangements in radiation-induced papillary thyroid carcinomas: high prevalence of topoisomerase I sites at breakpoints and microhomology-mediated end joining in ELE1 and RET chimeric genes.辐射诱导的甲状腺乳头状癌中的RET重排:断点处拓扑异构酶I位点的高发生率以及ELE1和RET嵌合基因中的微同源性介导的末端连接
Genomics. 2001 Apr 15;73(2):149-60. doi: 10.1006/geno.2000.6434.

引用本文的文献

1
A post-irradiation-induced replication stress promotes RET proto-oncogene breakage.辐照诱导的复制应激促进 RET 原癌基因断裂。
Eur Thyroid J. 2024 Aug 23;13(4). doi: 10.1530/ETJ-24-0028. Print 2024 Aug 1.
2
CCDC6-RET fusion protein regulates Ras/MAPK signaling through the fusion- GRB2-SHC1 signal niche.CCDC6-RET 融合蛋白通过融合-GRB2-SHC1 信号生态位调节 Ras/MAPK 信号通路。
Proc Natl Acad Sci U S A. 2024 Jun 4;121(23):e2322359121. doi: 10.1073/pnas.2322359121. Epub 2024 May 28.
3
Targeted treatments after chemoradiotherapy failure in a patient with relapsed, advanced non‑small cell lung cancer with on‑therapy circulating tumor biomarker monitoring: A case report.

本文引用的文献

1
Over half of breakpoints in gene pairs involved in cancer-specific recurrent translocations are mapped to human chromosomal fragile sites.参与癌症特异性复发性易位的基因对中,超过一半的断点被定位到人类染色体脆弱位点。
BMC Genomics. 2009 Jan 30;10:59. doi: 10.1186/1471-2164-10-59.
2
Replication timing of two human common fragile sites: FRA1H and FRA2G.两个人类常见脆性位点FRA1H和FRA2G的复制时间。
Cytogenet Genome Res. 2008;121(3-4):196-200. doi: 10.1159/000138885. Epub 2008 Aug 28.
3
Thyroid carcinoma: molecular pathways and therapeutic targets.
复发性晚期非小细胞肺癌患者放化疗失败后靶向治疗并进行治疗期间循环肿瘤生物标志物监测:一例报告
Oncol Lett. 2023 Aug 2;26(3):407. doi: 10.3892/ol.2023.13993. eCollection 2023 Sep.
4
rearrangements are relevant to histopathologic subtypes and clinicopathological features in Thai papillary thyroid carcinoma patients.重排与泰国甲状腺乳头状癌患者的组织病理学亚型和临床病理特征相关。
Pathol Oncol Res. 2023 Apr 28;29:1611138. doi: 10.3389/pore.2023.1611138. eCollection 2023.
5
Assessing acute myeloid leukemia susceptibility in rearrangement-driven patients by DNA breakage at topoisomerase II and CCCTC-binding factor/cohesin binding sites.通过拓扑异构酶 II 和 CCCTC 结合因子/黏合素结合位点的 DNA 断裂评估重排驱动患者的急性髓系白血病易感性。
Genes Chromosomes Cancer. 2021 Dec;60(12):808-821. doi: 10.1002/gcc.22993. Epub 2021 Aug 26.
6
Targeting Rearranged during Transfection in Cancer: A Perspective on Small-Molecule Inhibitors and Their Clinical Development.靶向转染过程中的重排肿瘤:小分子抑制剂及其临床开发的新视角。
J Med Chem. 2021 Aug 26;64(16):11747-11773. doi: 10.1021/acs.jmedchem.0c02167. Epub 2021 Aug 17.
7
Communicating with residents about 10 years of scientific progress in understanding thyroid cancer risk in children after the Fukushima Dai-ichi Nuclear Power Station accident.与居民沟通福岛第一核电站事故后 10 年来对儿童甲状腺癌风险认识的科学进展。
J Radiat Res. 2021 May 5;62(Supplement_1):i7-i14. doi: 10.1093/jrr/rraa097.
8
Identifying Thyroid Carcinoma-Related Genes by Integrating GWAS and eQTL Data.整合全基因组关联研究(GWAS)和表达定量性状位点(eQTL)数据以鉴定甲状腺癌相关基因
Front Cell Dev Biol. 2021 Feb 4;9:645275. doi: 10.3389/fcell.2021.645275. eCollection 2021.
9
The relationship between chimeric RNAs and gene fusions: Potential implications of reciprocity in cancer.嵌合RNA与基因融合之间的关系:癌症中相互作用的潜在影响
J Genet Genomics. 2020 Jul 20;47(7):341-348. doi: 10.1016/j.jgg.2020.04.005. Epub 2020 Jun 14.
10
RET Gene Fusions in Malignancies of the Thyroid and Other Tissues.RET 基因融合在甲状腺和其他组织恶性肿瘤中的作用。
Genes (Basel). 2020 Apr 15;11(4):424. doi: 10.3390/genes11040424.
甲状腺癌:分子途径与治疗靶点
Mod Pathol. 2008 May;21 Suppl 2(Suppl 2):S37-43. doi: 10.1038/modpathol.2008.10.
4
The endless tale of non-homologous end-joining.非同源末端连接的无尽故事。
Cell Res. 2008 Jan;18(1):114-24. doi: 10.1038/cr.2008.3.
5
Replication stress induces tumor-like microdeletions in FHIT/FRA3B.复制应激在FHIT/FRA3B中诱导肿瘤样微缺失。
Proc Natl Acad Sci U S A. 2008 Jan 8;105(1):246-51. doi: 10.1073/pnas.0708097105. Epub 2007 Dec 27.
6
Regulation of DNA double-strand break repair pathway choice.DNA双链断裂修复途径选择的调控
Cell Res. 2008 Jan;18(1):134-47. doi: 10.1038/cr.2007.111.
7
Molecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosis.甲状腺癌的分子遗传学:对诊断、治疗及预后的影响
Expert Rev Mol Diagn. 2008 Jan;8(1):83-95. doi: 10.1586/14737159.8.1.83.
8
The role of chromosomal alterations in human cancer development.染色体改变在人类癌症发展中的作用。
J Cell Biochem. 2007 Oct 1;102(2):320-31. doi: 10.1002/jcb.21481.
9
An AT-rich sequence in human common fragile site FRA16D causes fork stalling and chromosome breakage in S. cerevisiae.人类常见脆性位点FRA16D中的富含AT的序列在酿酒酵母中导致复制叉停滞和染色体断裂。
Mol Cell. 2007 Aug 3;27(3):367-79. doi: 10.1016/j.molcel.2007.06.012.
10
Chromosome fragile sites.染色体脆性位点
Annu Rev Genet. 2007;41:169-92. doi: 10.1146/annurev.genet.41.042007.165900.